operations in pharma operations in line with all safety, regulatory and organizational requirements. Are you intrigued... Desired: Three years plus of Knowledge of cGMP and regulatory requirements relating to the pharma/biologics industry...
We are delighted to be partnering with a leader in pharmaceutical distribution and healthcare solutions in their search for a Senior Product Lifecycle Manager. Are you an experienced Project Management Professional with a proven track rec...
services management on large scale industrial / Life Science or pharma projects? Our client has immediate requirements... Life Sciences/Industrial/Pharma preferable, and main contractor experience Requirements Previous Main Contractor...
Indian markets rebounded post Lok Sabha election results, focusing on the upcoming Union Budget 2024. Nifty surged over 4% in June. BP Wealth recommends 7 super picks for June including Cummins India, GAIL, and IRFC for short-term gains. Continue Reading »
UltraTech Cement, Adani Group (Ambuja Cements, ACC), Shree Cement, Dalmia Bharat, Nuvoco Vista: ICRA sees top 5 cement companies market share climbing to 55% by March 2025. Continue Reading »
Axis recommends constructing a diversified portfolio spanning multiple asset classes to safeguard against market volatility. The brokerage is overweight on equities, neutral on fixed-income assets and gold. Market dynamics will pivot around prevailing narratives, influencing investment decisions. Continue Reading »
Dabur shares have been Emkay Global’s preferred consumption pick given its relatively higher share of rural, diversified portfolios and its sustained thrust on NPDs. The brokerage firm has raised Dabur share price target to ₹700 per share from ₹660 earlier, and has a ‘Buy’ rating on the stock. Continue Reading »
Durlax Top Surface IPO GMP: Durlax Top Surface Limited Shares are available at a premium of ₹15 in the grey market today, say market observers. Continue Reading »
Akme Fintrade IPO GMP is at ₹33 per share, indicating a premium of 27.5% over the IPO price of ₹120. The IPO is set to launch next week with a price band of ₹114-120 per share. Continue Reading »